Abstract
The ubiquity of smartphones in modern life suggests the possibility to use them to continuously monitor patients, for instance to detect undiagnosed diseases or track treatment progress. Such data collection and analysis may be especially beneficial to patients with i.) mental disorders, as these individuals can experience intermittent symptoms and impaired decision-making, which may impede diagnosis and care-seeking, and ii.) progressive neurological diseases, as real-time monitoring could facilitate earlier diagnosis and more effective treatment. This paper presents a new method of leveraging passively-collected smartphone data and machine learning to detect and monitor brain disorders such as depression and Parkinson’s disease. Crucially, the algorithm is able learn accurate, interpretable models from small numbers of labeled examples (i.e., smartphone users for whom sensor data has been gathered and disease status has been determined). Predictive modeling is achieved by learning from both real patient data and ‘synthetic’ patients constructed via adversarial learning. The proposed approach is shown to outperform state-of-the-art techniques in experiments involving disparate brain disorders and multiple patient datasets.
Competing Interest Statement
Rich Colbaugh (RC) and Kristin Glass (KG) are shareholders in Volv Global SA.
Funding Statement
RC and KG are consultants to Volv Global SA.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Only de-identified publicly available data was used in this research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
See citations in the manuscript for data availability.
